Category: Press Release
SQ, XYZ IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Block, Inc. Investors to Secure Counsel Before Important March 18 Deadline in Securities Class Action – SQ, XYZ
NEW YORK, March 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Block, Inc. (NYSE: SQ, XYZ)
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NTLA
NEW YORK, March 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intellia Therapeutics, Inc. (NASDAQ: NTLA) between July 30,
FTAI DEADLINE TUESDAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages FTAI Aviation Ltd. Investors to Secure Counsel Before Important March 18 Deadline in Securities Class Action – FTAI
NEW YORK, March 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FTAI Aviation Ltd. (NASDAQ: FTAI) between July 23,
IIPR FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Innovative Industrial Properties, Inc. Investors to Secure Counsel Before Important March 18 Deadline in Securities Class Action — IIPR
NEW YORK, March 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innovative Industrial Properties, Inc. (NYSE: IIPR) between February
CGTN: Two years on, China’s Global Civilization Initiative gains greater relevance in a turbulent world
CGTN published an article on the second anniversary of China’s Global Civilization Initiative proposed by Chinese President Xi Jinping, which has become more relevant than ever amid uncertainty, turbulence and
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results
REGULATED INFORMATION Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results FDA PMA Application Review Nearing Conclusion Positioned for U.S. Commercial Launch in March 2025 Mont-Saint-Guibert, Belgium – March 13, 2024, 7:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive